4 | SEC Filings Hub

Filing metadata

Accession number: 0001104659-21-154012
Form type: Form 4
Filer: Nabriva Therapeutics plc
CIK: CIK 1641640
Filed: Dec 28, 2021
Reporting period: Dec 27, 2021
Description: Insider transaction

Documents

0001104659-21-154012-index.htm

Complete submission

0001104659-21-154012.txt

directory listing

Filed by

Nabriva Therapeutics plc